Armie Margaret Lee

Armie Margaret Lee is a reporter covering private equity. Previously, she was at InvestmentWires, an online media company that focuses on the mutual fund and 401(k) industries. She has also covered real estate and banking for Miami Today and technology for Manila Times in the Philippines.

Recent Articles By The Author

Intercept Sinks on Safety Issue, One Analyst Says Buy Anyway - Biotech Movers

Intercept Sinks on Safety Issue, One Analyst Says Buy Anyway - Biotech Movers

The FDA on Thursday issued a safety announcement saying Intercept's liver disease treatment Ocaliva is being dosed incorrectly in some patients.

Impax Shares Jump on Merger Buzz

Impax Shares Jump on Merger Buzz

Impax's shares soar after the Wall Street Journal reported that the drug maker is in merger discussions with Amneal Pharmaceuticals.

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

The approval marks "the first new influenza antiviral for pediatric use in over 10 years," said BioCryst president and CEO Jon Stonehouse in the news release.

Alnylam Shares Skyrocket on Clinical Study Results - Biotech Movers

Alnylam Shares Skyrocket on Clinical Study Results - Biotech Movers

Alnylam and Sanofi Genzyme announced positive topline results from a Phase 3 study of patisiran, which is being developed for patients with hereditary ATTR amyloidosis with polyneuropathy.

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.